Meningococcal Polysaccharide AO-Acetylation Levels Do Not Impact the Immunogenicity of the Quadrivalent Meningococcal Tetanus Toxoid Conjugate Vaccine: Results from a Randomized, Controlled Phase III Study of Healthy Adults Aged 18 to 25 Years
出版年份 2013 全文链接
标题
Meningococcal Polysaccharide AO-Acetylation Levels Do Not Impact the Immunogenicity of the Quadrivalent Meningococcal Tetanus Toxoid Conjugate Vaccine: Results from a Randomized, Controlled Phase III Study of Healthy Adults Aged 18 to 25 Years
作者
关键词
-
出版物
Clinical and Vaccine Immunology
Volume 20, Issue 10, Pages 1499-1507
出版商
American Society for Microbiology
发表日期
2013-07-25
DOI
10.1128/cvi.00162-13
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The epidemiology of meningococcal disease in Latin America 1945–2010: an unpredictable and changing landscape
- (2012) M. A. P. SÁFADI et al. EPIDEMIOLOGY AND INFECTION
- The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine
- (2012) Ghassan Dbaibo et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Laboratory-Based Surveillance of Neisseria meningitidis Isolates from Disease Cases in Latin American and Caribbean Countries, SIREVA II 2006–2010
- (2012) Ana Belén Ibarz-Pavón et al. PLoS One
- The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine
- (2012) Ghassan Dbaibo et al. Human Vaccines & Immunotherapeutics
- Maintenance of Immune Response throughout Childhood following Serogroup C Meningococcal Conjugate Vaccination in Early Childhood
- (2011) A. Khatami et al. Clinical and Vaccine Immunology
- Meningococcal disease in Asia: an under-recognized public health burden
- (2011) A. VYSE et al. EPIDEMIOLOGY AND INFECTION
- Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
- (2011) Nancy Bermal et al. Human vaccines & immunotherapeutics
- Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2- to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile
- (2011) Ziad A. Memish et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age
- (2011) Roger Baxter et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix® in subjects aged 11–17 years: An open, randomised, controlled trial
- (2011) Lars Østergaard et al. VACCINE
- Meningococcal conjugate vaccines: optimizing global impact
- (2011) Andrew Terranella et al. Infection and Drug Resistance
- Meningococcal Quadrivalent (Serogroups A, C, W135, and Y) Conjugate Vaccine (Menveo®)
- (2010) Emma D. Deeks BIODRUGS
- Epidemiological Profile of Meningococcal Disease in the United States
- (2010) Lee H. Harrison CLINICAL INFECTIOUS DISEASES
- The epidemiology of meningococcal disease and the impact of vaccines
- (2010) Ameneh Khatami et al. Expert Review of Vaccines
- Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y
- (2010) Brian Cooper et al. Expert Review of Vaccines
- Advances in the Development of Vaccines againstNeisseria meningitidis
- (2010) Lionel K.K. Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
- W135 Invasive Meningococcal Strains Spreading in South America: Significant Increase in Incidence Rate in Argentina
- (2009) A. M. Efron et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
- (2009) Pei-Lan Shao et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Meningococcal carriage and disease—Population biology and evolution
- (2009) Dominique A. Caugant et al. VACCINE
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
- A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children
- (2009) M. Knuf et al. VACCINE
- Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age
- (2009) S. Black et al. VACCINE
- Emergence of Endemic Serogroup W135 Meningococcal Disease Associated with a High Mortality Rate in South Africa
- (2008) A. von Gottberg et al. CLINICAL INFECTIOUS DISEASES
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
- (2008) Martin C. J. Maiden et al. JOURNAL OF INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started